Covalent Bruton tyrosine kinase inhibitors (BTKis) have improved CLL management, but discontinuation due to adverse events ...

High risk of obstructive sleep apnea (OSA) is linked to a 40% increase in poor mental health outcomes, including depression ...

Here are the most-read “5 things” articles from 2025.

The 30th European Hematology Association (EHA) Congress (EHA 2025), held in Milan, Italy, from June 12-15, 2025, continued ...

As therapy for chronic lymphocytic leukemia (CLL) continues to evolve, 2025 brought research, regulatory news, and expert ...

CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels indicating severe cases and recurrent wheezing, respectively. RSV remains a major ...

The top 5 most-viewed videos of 2025 explored a range of topics, including data presented at major medical meetings, health ...

Here are our top highlights from AAD 2025 that include safety of topical JAK inhibitors, climate impacts on skin health, ...

Key barriers include misdiagnosis, insufficient gMG knowledge among healthcare providers, and limited access to specialists, ...

Here are the top IVBM articles from 2025 capturing how value-based strategies are translating into real-world impact. Click ...

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...

Here are the top 5 AJMC.com articles and videos on allergy for 2025.